plerixafor has been researched along with Breast Cancer in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 20 (86.96) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, R; Liang, Z; Shim, H; Wu, R; Xie, Y; Yao, C; Yoon, Y; Yu, W | 1 |
| Arteaga, CL; Chu, F; Gagea, M; Hanash, S; Hanker, AB; Liu, S; Liu, W; Marchese, A; Neelapu, SS; Nguyen, N; Singareeka Raghavendra, A; Tripathy, D; Xie, SM; Yang-Kolodji, G; Zimmermann, J | 1 |
| He, J; Kong, J; Lin, B; Liu, T; Lu, Y; Luo, Y; Ma, H; Pang, J; Qin, K; Tian, H; Yang, X; Yuan, W | 1 |
| Jiang, J; Li, G; Sakurai, K; Shen, N; Song, W; Tang, Z; Yu, H | 1 |
| Gong, S; Li, H; Oupicky, D; Sun, M; Wu, J; Zhang, F | 1 |
| Li, C; Li, H; Oupicky, D; Qiao, H; Sun, M; Wang, K; Yang, X; Zhou, Z | 1 |
| Chan, WC; Hao, Y; Ng, TB; Pan, WL; Wan, DC; Wang, Y; Wong, JH | 1 |
| Barbul, A; Busch, JI; Cervoni-Curet, FN; Kavalukas, SL; Niederhuber, JE; Stuelten, CH; Sutton, E; Wakefield, LM; Webster, JD | 1 |
| Ablett, MP; Clarke, RB; Farnie, G; O'Brien, CS; Sims, AH | 1 |
| Cavnar, SP; Chang, SL; Linderman, JJ; Luker, GD; Luker, KE; Moudgil, P; Ray, P; Takayama, S | 1 |
| Hans, F; Hattermann, K; Held-Feindt, J; Holzenburg, E; Lucius, R; Mentlein, R | 1 |
| Balboni, A; Cherukuri, P; DeCastro, AJ; DiRenzo, J | 1 |
| Duvall-Noelle, N; Karwandyar, A; Raman, D; Richmond, A | 1 |
| Bracke, M; De Wagter, C; De Wever, O; Descamps, B; Feys, L; Vanhove, C; Veldeman, L; Vermeulen, S; Vral, A | 1 |
| An, F; Fang, S; Jin, D; Kong, J; Li, J; Li, X; Lin, B; Liu, L; Liu, T; Luo, Y; Yang, X; Zhang, W | 1 |
| Burness, ML; Cheng, Q; Cheng, R; Comatas, K; Kim Lyerly, H; Lee, CH; Magnani, J; McCall, CM; Olivere, L; Price, TT; Sipkins, DA; Sivan, A; Warner, MJ | 1 |
| Bieche, I; Kieffer, Y; Lefort, S; Marangoni, E; Mechta-Grigoriou, F; Sirven, P; Thuleau, A; Vincent-Salomon, A | 1 |
| Li, H; Oupicky, D; Ping, Q; Sun, M; Wang, K; Yang, X; Zhou, Y | 1 |
| Cronin, PA; Redmond, HP; Wang, JH | 1 |
| Antoon, JW; Beckman, BS; Burow, ME; Elliott, S; Muir, SE; Rhodes, LV | 1 |
| Bratton, MR; Burow, ME; Collins-Burow, BM; Elliott, S; Muir, SE; Nephew, KP; Rhodes, LV; Salvo, VA; Tate, CR; Tilghman, SL; Zhu, Y | 1 |
| Chudakov, DM; Lewin, SA; Luker, GD; Luker, KE; Mihalko, LA; Ray, P; Schmidt, BT; Shcherbo, D | 1 |
| Bouchez, LC; Cho, CY; Dubrovska, A; Hartung, A; Reddy, VA; Schultz, PG; Walker, JR | 1 |
23 other study(ies) available for plerixafor and Breast Cancer
| Article | Year |
|---|---|
Amide-sulfamide modulators as effective anti-tumor metastatic agents targeting CXCR4/CXCL12 axis.
Topics: Amides; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Adhesion; Cell Proliferation; Chemokine CXCL12; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Injections, Intravenous; Lung Neoplasms; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Receptors, CXCR4; Structure-Activity Relationship; Tumor Cells, Cultured; Wound Healing | 2020 |
Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Female; G2 Phase Cell Cycle Checkpoints; Humans; Leukocytes, Mononuclear; Mice; Mitosis; Receptor, ErbB-2; Receptors, CXCR4; Trastuzumab; Tumor Microenvironment | 2023 |
A Novel Tissue-Based Liver-Kidney-on-a-Chip Can Mimic Liver Tropism of Extracellular Vesicles Derived from Breast Cancer Cells.
Topics: Animals; Benzylamines; Biomimetics; Breast Neoplasms; Cyclams; Extracellular Vesicles; Female; Heterocyclic Compounds; Humans; Kidney; Lab-On-A-Chip Devices; Liver; Microfluidics; Neoplasm Metastasis; Oligonucleotide Array Sequence Analysis; Tropism | 2020 |
Combretastatin A4 nanodrug combined plerixafor for inhibiting tumor growth and metastasis simultaneously.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzylamines; Breast Neoplasms; Cell Proliferation; Cell Survival; Cyclams; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Lung Neoplasms; Mice; Receptors, CXCR4; Stilbenes; Theranostic Nanomedicine; Up-Regulation; Xenograft Model Antitumor Assays | 2019 |
CXCR4-Targeted and Redox Responsive Dextrin Nanogel for Metastatic Breast Cancer Therapy.
Topics: Animals; Antibiotics, Antineoplastic; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL12; Cyclams; Dextrins; Doxorubicin; Drug Carriers; Female; Gels; Gene Expression; Heterocyclic Compounds; Humans; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Nanostructures; Neoplasm Proteins; Oxidation-Reduction; Protein Binding; Receptors, CXCR4; Xenograft Model Antitumor Assays | 2017 |
Near-infrared light-triggered drug release from a multiple lipid carrier complex using an all-in-one strategy.
Topics: Animals; Benzylamines; Breast Neoplasms; Cyclams; Drug Carriers; Drug Delivery Systems; Drug Liberation; Female; Heterocyclic Compounds; Hydrophobic and Hydrophilic Interactions; Indoles; Infrared Rays; Lipids; Liposomes; Mice; Mice, Inbred BALB C; Nanostructures; Neoplasm Metastasis | 2017 |
Overexpression of CXCR4 synergizes with LL-37 in the metastasis of breast cancer cells.
Topics: Adult; Aged; Antimicrobial Cationic Peptides; Benzylamines; Binding Sites; Breast; Breast Neoplasms; Cathelicidins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclams; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Lymphatic Metastasis; Mesenchymal Stem Cells; Middle Aged; Molecular Docking Simulation; Protein Binding; Receptors, CXCR4; Signal Transduction; Tumor Microenvironment; Up-Regulation | 2018 |
SDF-1α mediates wound-promoted tumor growth in a syngeneic orthotopic mouse model of breast cancer.
Topics: Analysis of Variance; Animals; Azo Compounds; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chemokine CXCL12; Collagen; Cyclams; Enzyme-Linked Immunosorbent Assay; Female; Heterocyclic Compounds; Immunohistochemistry; Mice; Mice, Inbred BALB C; Microarray Analysis; Signal Transduction; Statistics, Nonparametric; Wounds and Injuries | 2013 |
A differential role for CXCR4 in the regulation of normal versus malignant breast stem cell activity.
Topics: Anoikis; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Cyclams; Female; Gene Expression; Heterocyclic Compounds; Humans; MCF-7 Cells; Neoplastic Stem Cells; Receptors, CXCR4; Signal Transduction | 2014 |
Microfluidic source-sink model reveals effects of biophysically distinct CXCL12 isoforms in breast cancer chemotaxis.
Topics: Animals; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Chemokine CXCL12; Chemotaxis; Cyclams; Female; Heterocyclic Compounds; Humans; Mice, Inbred C57BL; Microfluidics; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Protein Isoforms; Receptors, CXCR; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm | 2014 |
Effects of the chemokine CXCL12 and combined internalization of its receptors CXCR4 and CXCR7 in human MCF-7 breast cancer cells.
Topics: Apoptosis; Benzylamines; Breast Neoplasms; Chemokine CXCL12; Cyclams; Female; Heterocyclic Compounds; Humans; Ligands; MCF-7 Cells; Receptors, CXCR; Receptors, CXCR4; Signal Transduction; Stimulation, Chemical | 2014 |
ΔNP63α transcriptionally activates chemokine receptor 4 (CXCR4) expression to regulate breast cancer stem cell activity and chemotaxis.
Topics: Benzylamines; Breast Neoplasms; Cell Line, Tumor; Chemotaxis; Cyclams; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; MCF-7 Cells; Neoplastic Stem Cells; Promoter Regions, Genetic; Protein Isoforms; Receptors, CXCR4; Transcription Factors; Tumor Suppressor Proteins | 2015 |
LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex.
Topics: Active Transport, Cell Nucleus; Adaptor Proteins, Signal Transducing; Benzylamines; Breast Neoplasms; CCAAT-Enhancer-Binding Proteins; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Cytoskeletal Proteins; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Epigenesis, Genetic; Gene Knockdown Techniques; Heterocyclic Compounds; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Histones; Humans; LIM Domain Proteins; Prognosis; Proteomics; Signal Transduction; Snail Family Transcription Factors; Transcription Factors; Tumor Microenvironment; Ubiquitin-Protein Ligases | 2016 |
Radiation-induced lung damage promotes breast cancer lung-metastasis through CXCR4 signaling.
Topics: Animals; Benzylamines; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Survival; Cellular Senescence; Chemokine CXCL12; Culture Media, Conditioned; Cyclams; DNA Breaks, Double-Stranded; Extracellular Signal-Regulated MAP Kinases; Female; Heterocyclic Compounds; Humans; Intramolecular Oxidoreductases; Lung; Lung Diseases; Lung Neoplasms; Macrophage Migration-Inhibitory Factors; Mice; Neoplasm Metastasis; Neoplasm Transplantation; Proto-Oncogene Proteins c-akt; Radiotherapy; Receptors, CXCR4; Recombinant Proteins; Signal Transduction; STAT3 Transcription Factor | 2015 |
A novel microfluidic model can mimic organ-specific metastasis of circulating tumor cells.
Topics: Animals; Antineoplastic Agents; Benzylamines; Breast Neoplasms; Cell Adhesion; Cell Movement; Chemokines; Coculture Techniques; Cyclams; Female; Heterocyclic Compounds; Human Umbilical Vein Endothelial Cells; Humans; Lab-On-A-Chip Devices; Lung Neoplasms; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Microfluidic Analytical Techniques; Neoplasm Invasiveness; Neoplastic Cells, Circulating; Organ Specificity; Primary Cell Culture; Rats, Sprague-Dawley; Salivary Gland Neoplasms; Time Factors | 2016 |
Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone.
Topics: Animals; Benzylamines; Bone Marrow; Breast Neoplasms; Cell Line, Tumor; Chemokine CXCL12; Cyclams; E-Selectin; Female; Flow Cytometry; Heterocyclic Compounds; Humans; Immunohistochemistry; MCF-7 Cells; Mice; Mice, SCID; Microscopy, Confocal; Neoplasm Micrometastasis; Neoplasm Recurrence, Local; Protein Binding; Receptors, CXCR4; Tumor Cells, Cultured | 2016 |
CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients.
Topics: Animals; Anti-HIV Agents; Apoptosis; Benzylamines; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Cyclams; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Lung Neoplasms; Mice; Neoplasm Invasiveness; Neovascularization, Pathologic; Peptides; Receptor, ErbB-2; Receptors, CXCR4; Signal Transduction; Triple Negative Breast Neoplasms; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |
Dual-function nanostructured lipid carriers to deliver IR780 for breast cancer treatment: Anti-metastatic and photothermal anti-tumor therapy.
Topics: Animals; Antineoplastic Agents; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Combined Modality Therapy; Cyclams; Delayed-Action Preparations; Female; Heterocyclic Compounds; Indoles; Lipids; Liposomes; Lymphatic Metastasis; Mice; Mice, Inbred BALB C; Nanocapsules; Particle Size; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2017 |
Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4.
Topics: Animals; Antibodies, Monoclonal; Benzylamines; Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Cell Membrane; Chemokine CXCL12; Chemotaxis; Cyclams; Female; Flow Cytometry; Heterocyclic Compounds; Humans; Mice; Neoplasm Invasiveness; Receptors, CXCR4; Recombinant Proteins; Time Factors; Up-Regulation | 2010 |
Effects of human mesenchymal stem cells on ER-positive human breast carcinoma cells mediated through ER-SDF-1/CXCR4 crosstalk.
Topics: Benzylamines; Breast Neoplasms; Carcinoma; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cells, Cultured; Chemokine CXCL12; Coculture Techniques; Cyclams; Female; Flow Cytometry; Heterocyclic Compounds; Humans; Mesenchymal Stem Cells; Microscopy, Fluorescence; Receptors, CXCR4; Receptors, Estrogen; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction | 2010 |
Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells.
Topics: Animals; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Estrogen Receptor alpha; Female; Gene Expression Profiling; Heterocyclic Compounds; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; MicroRNAs; Polymerase Chain Reaction; Receptors, CXCR4; Signal Transduction | 2011 |
In vivo imaging of ligand receptor binding with Gaussia luciferase complementation.
Topics: Animals; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Chemokine CXCL12; Cyclams; Female; HEK293 Cells; Heterocyclic Compounds; Humans; Ligands; Luciferases; Luminescent Measurements; Mice; Molecular Imaging; Neoplasms, Experimental; Protein Binding; Receptors, CXCR; Receptors, CXCR4 | 2011 |
CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling.
Topics: Animals; Antineoplastic Agents, Hormonal; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzylamines; Breast Neoplasms; Cell Line, Tumor; Cyclams; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Humans; Mice; Mice, Nude; Neoplasm Proteins; Neoplasm Transplantation; Neoplastic Stem Cells; Receptors, Aryl Hydrocarbon; Receptors, CXCR4; Signal Transduction; Tamoxifen; Transcriptional Activation; Transplantation, Heterologous | 2012 |